Tisdag 17 November | 13:01:40 Europe / Stockholm
Est. tid*
2027-02-25 14:30 Bokslutskommuniké 2026
2026-11-18 13:30 Kvartalsrapport 2026-Q3
2026-08-19 - Kvartalsrapport 2026-Q2
2026-07-22 - Extra Bolagsstämma 2026
2026-05-22 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2026-05-21 - Årsstämma
2026-05-21 - Kvartalsrapport 2026-Q1
2026-02-26 - Bokslutskommuniké 2025
2025-11-20 - Kvartalsrapport 2025-Q3
2025-08-21 - Kvartalsrapport 2025-Q2
2025-05-23 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2025-05-22 - Årsstämma
2025-05-22 - Kvartalsrapport 2025-Q1
2025-02-27 - Bokslutskommuniké 2024
2024-11-19 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2024-05-23 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-02-29 - Bokslutskommuniké 2023
2024-02-05 - Extra Bolagsstämma 2024
2023-11-23 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-15 - Split COEGIN 100:1
2023-05-26 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2023-05-25 - Årsstämma
2023-05-25 - Kvartalsrapport 2023-Q1
2023-02-27 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-27 - Årsstämma
2021-05-21 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-09-29 - Extra Bolagsstämma 2020
2020-08-28 - Kvartalsrapport 2020-Q2
2020-04-15 - Inlösen COEGIN 0.1
2020-04-03 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2020-04-02 - Årsstämma
2020-02-21 - Bokslutskommuniké 2019
2019-11-23 - Kvartalsrapport 2019-Q3
2019-09-09 - Extra Bolagsstämma 2019
2019-08-24 - Kvartalsrapport 2019-Q2
2019-06-18 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2019-06-17 - Årsstämma
2019-03-16 - Kvartalsrapport 2019-Q1
2019-02-22 - Bokslutskommuniké 2018
2018-08-24 - Kvartalsrapport 2018-Q2
2018-06-20 - Årsstämma
2018-06-07 - X-dag ordinarie utdelning COEGIN 0.00 SEK
2018-02-23 - Bokslutskommuniké 2017
LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriBioteknik
Coegin Pharma är ett svenskt innovationsbolag som utvecklar och kommersialiserar vetenskapsbaserade teknologier för hår och hud. Bolagets patenterade ingrediens för hårtillväxt finns nu i produkter som säljs genom utvalda partners såväl som via bolagets eget varumärke. I utveckling finns även en peptid för naturlig hudpigmentering med planerad lansering i närtid. Coegin Pharma har sitt huvudkontor i Lund.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Coegin Pharma strengthens Danish pharmacy presence - VEXIENNE® expands to Køge and southern Zealand

2026-11-16 09:50:00

Coegin Pharma AB ("Coegin" or the "Company") today announces a collaboration with Køge Boholte Apotek, a pharmacy operator with four locations in Køge and southern Zealand, to introduce VEXIENNE® Hair Active X™ to its customers. The initial launch will cover two pharmacies before the end of 2026 and follows the collaboration with Taastrup Apotek announced on 13 November 2026.

With the two collaborations (Taastrup Apotek and Køge Boholte Apotek), VEXIENNE® will be introduced at five Danish pharmacies in Greater Copenhagen and on Zealand. Together with the recently announced agreement with MEDS in Sweden, they strengthen Coegin's Nordic distribution footprint and advance its strategy to scale Follicopeptide® through selected pharmacy, clinic and professional partners.

Hair Active X™ is a premium cosmetic gel serum powered by Follicopeptide®, Coegin's patented and clinically developed peptide technology for thinning hair. Deliveries to the pharmacies are planned for November, with in-store availability expected before year-end.

"Only days after announcing our collaboration with Taastrup Apotek, we are adding a second Danish pharmacy partner. The two complement each other very well: Taastrup Apotek with its strong presence in central and Greater Copenhagen, and Køge Boholte Apotek with its reach across Zealand and online. Both are led by forward-looking pharmacists, and together they give us a strong base in the Danish pharmacy channel," says Jens Eriksson, CEO of Coegin Pharma.

"Our customers ask for serious, science-based options for thinning hair, and we want to offer them a credible choice. Hair Active X™ fits well with the personal advice our staff give every day, and we look forward to offering it in our pharmacies," says Troels Ravn, pharmacy owner, Køge Boholte Apotek.

The initial introduction will take place at Køge Boholte Apotek in Køge and Rønnede Apotek on southern Zealand, with preparations under way for the planned launch before the end of 2026.

The agreement complements Coegin's existing private label partnerships and VEXIENNE® distribution model, supporting a broader and more diversified commercial footprint.

For further information, please contact:
Jens Eriksson, CEO, or Lars B. Rasmussen, CFO
Email: info@coeginpharma.com
Phone: 072-221 24 21

About Køge Boholte Apotek
Led by pharmacist Troels Ravn, Køge Boholte Apotek operates four pharmacies in Køge and southern Zealand: Køge Boholte Apotek, Ølby Apotek, Herfølge Apotek and Rønnede Apotek. The group also has a strong online presence, offering online ordering and home delivery of medicines. The pharmacies combine accessible healthcare products with qualified, personal advice on medicines and health-related products.

About Coegin Pharma
Coegin Pharma is a Swedish innovation company developing and commercializing advanced cosmetic technologies for hair and skin. Its flagship innovation, Follicopeptide®, is a patented, clinically developed peptide technology targeting hair thinning, commercialized through selected partners and the Company's VEXIENNE® brand. Coegin is also developing NPP-4, a next-generation cosmetic peptide innovation for skin tone enhancement.

With proprietary peptide technology, scalable in-house production and flexible commercial models, Coegin is building a differentiated platform for science-based cosmetic products.

Coegin Pharma's share is listed on NGM Nordic SME and dual-listed on Börse Stuttgart. The Company is headquartered in Lund, Sweden.

For more information, including company updates and social media links, visit www.coeginpharma.com